

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 256.43 |
| Log P | RDKit | 5.55 |
| Topological polar surface area (Å2) | RDKit | 37.3 |
| Number of hydrogen bond acceptors | RDKit | 1 |
| Number of hydrogen bond donors | RDKit | 1 |
| Number of carbon atoms | RDKit | 16 |
| Number of heavy atoms | RDKit | 18 |
| Number of heteroatoms | RDKit | 2 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 0 |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 1 |
| Number of sp3 hybridized carbon atoms | RDKit | 15 |
| Shape complexity | RDKit | 0.94 |
| Number of rotatable bonds | RDKit | 14 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 0 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 0 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 0 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 1 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Bad |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.41349 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.85 |
| Solubility class [ESOL] | SwissADME | Moderately soluble |
| Solubility class [Silicos-IT] | SwissADME | Moderately soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -2.77 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | Yes |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | Yes |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_001942 | ENSG00000012504 | NR1H4 | 9971 | NPASS |
| TAR_EXP_000419 | ENSG00000164687 | FABP5 | 2171 | ChEMBL, NPASS |
| TAR_EXP_000285 | ENSG00000137869 | CYP19A1 | 1588 | ChEMBL, NPASS |
| TAR_EXP_000414 | ENSG00000170323 | FABP4 | 2167 | ChEMBL, NPASS |
| TAR_EXP_000416 | ENSG00000145384 | FABP2 | 2169 | ChEMBL, NPASS |
| TAR_EXP_000418 | ENSG00000121769 | FABP3 | 2170 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001739 | ENSG00000167332 | OR51E2 | 81285 | ChEMBL, NPASS |
| TAR_EXP_001663 | ENSG00000162607 | USP1 | 7398 | NPASS |
| TAR_EXP_000645 | ENSG00000113580 | NR3C1 | 2908 | NPASS |
| TAR_EXP_001596 | ENSG00000197905 | TEAD4 | 7004 | ChEMBL |
| TAR_EXP_000773 | ENSG00000169083 | AR | 367 | NPASS |
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | NPASS |
| TAR_EXP_001613 | ENSG00000137462 | TLR2 | 7097 | ChEMBL, NPASS |
| TAR_EXP_001031 | ENSG00000112312 | GMNN | 51053 | NPASS |
| TAR_EXP_001106 | ENSG00000085563 | ABCB1 | 5243 | ChEMBL |
| TAR_EXP_000395 | ENSG00000091831 | ESR1 | 2099 | ChEMBL, NPASS |
| TAR_EXP_001170 | ENSG00000112033 | PPARD | 5467 | ChEMBL, NPASS |
| TAR_EXP_001171 | ENSG00000132170 | PPARG | 5468 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001306 | ENSG00000196396 | PTPN1 | 5770 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001166 | ENSG00000186951 | PPARA | 5465 | ChEMBL, NPASS |